Roxana Mehran
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Cardiac Valve Diseases and Treatments
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Acute Myocardial Infarction Research 578
- Antiplatelet Therapy and Cardiovascular Diseases 355
- Atrial Fibrillation Management and Outcomes 157
- Cardiac Valve Diseases and Treatments 113
- Surgery 783
- Coronary Interventions and Diagnostics 674
- Co-authors
- Gregg W. Stone (251 shared papers)Alexandra J. Lansky (251 shared papers)George Dangas (251 shared papers)Martin B. Leon (227 shared papers)Gary S. Mintz (185 shared papers)Eugenia Nikolsky (81 shared papers)Jeffrey W. Moses (138 shared papers)Martin Fahy (129 shared papers)
- Journals
- Journal of the American College of Cardiology (281 papers)The American Journal of Cardiology (185 papers)Catheterization and Cardiovascular Interventions (80 papers)Circulation (73 papers)JACC: Cardiovascular Interventions (70 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Roxana Mehran
1.2k papers receiving 74.2k citations
Roxana Mehran's Hit Papers
Peers
Comparison fields: 5 of 184
- Cardiology and Cardiovascular Medicine 53.3k
- Internal Medicine 7.6k
- Radiology, Nuclear Medicine and Imaging 22.8k
- Surgery 42.6k
- Nephrology 6.2k
Countries citing papers authored by Roxana Mehran
This map shows the geographic impact of Roxana Mehran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana Mehran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana Mehran more than expected).
Fields of papers citing papers by Roxana Mehran
This network shows the impact of papers produced by Roxana Mehran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana Mehran. The network helps show where Roxana Mehran may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxana Mehran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.3k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical End Points in Coronary Stent Trials Hit paper breakdown → | 2007 | 4204 |
| 2 | Standardized Bleeding Definitions for Cardiovascular Clinical Trials Hit paper breakdown → | 2011 | 2948 |
| 3 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Hit paper breakdown → | 2011 | 2436 |
| 4 | A Prospective Natural-History Study of Coronary Atherosclerosis Hit paper breakdown → | 2011 | 2137 |
| 5 | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention Hit paper breakdown → | 2004 | 1598 |
| 6 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention Hit paper breakdown → | 2011 | 1523 |
| 7 | Bivalirudin during Primary PCI in Acute Myocardial Infarction Hit paper breakdown → | 2008 | 1222 |
| 8 | Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary Stents Hit paper breakdown → | 2007 | 1199 |
| 9 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease Hit paper breakdown → | 2016 | 1046 |
| 10 | Angiographic Patterns of In-Stent Restenosis Hit paper breakdown → | 1999 | 986 |
| 11 | Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI Hit paper breakdown → | 2016 | 942 |
| 12 | Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium Hit paper breakdown → | 2011 | 897 |
| 13 | 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery Hit paper breakdown → | 2016 | 895 |
| 14 | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation Hit paper breakdown → | 2004 | 893 |
| 15 | Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease Hit paper breakdown → | 2016 | 857 |
| 16 | The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 Hit paper breakdown → | 2021 | 762 |
| 17 | Contrast-induced nephropathy: Definition, epidemiology, and patients at risk Hit paper breakdown → | 2006 | 655 |
| 18 | Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study Hit paper breakdown → | 2013 | 613 |
| 19 | Impact of Major Bleeding on 30-Day Mortality and Clinical Outcomes in Patients With Acute Coronary Syndromes Hit paper breakdown → | 2007 | 604 |
| 20 | In-Stent Restenosis in the Drug-Eluting Stent Era Hit paper breakdown → | 2010 | 591 |
About Roxana Mehran
Roxana Mehran is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 1.3k papers that have together received 76.4k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (674 papers), Acute Myocardial Infarction Research (578 papers), Cardiac Imaging and Diagnostics (376 papers), Antiplatelet Therapy and Cardiovascular Diseases (355 papers), Atrial Fibrillation Management and Outcomes (157 papers), Venous Thromboembolism Diagnosis and Management (126 papers), Cardiac Valve Diseases and Treatments (113 papers) and Cerebrovascular and Carotid Artery Diseases (85 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (53.3k citations), Internal Medicine (7.6k citations), Radiology, Nuclear Medicine and Imaging (22.8k citations), Surgery (42.6k citations) and Nephrology (6.2k citations). Roxana Mehran has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Gregg W. Stone, Alexandra J. Lansky, George Dangas, Martin B. Leon, Gary S. Mintz, Eugenia Nikolsky, Jeffrey W. Moses, Martin Fahy, Donald E. Cutlip and Pascal Vranckx. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Cardiology, Catheterization and Cardiovascular Interventions, Circulation and JACC: Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.